Pharmaceuticals
PE firms in race for J&J’s Ortho Clinical Diagnostics unit
01 Oct 2013
Private equity firms have tabled preliminary bids for Johnson & Johnson's Ortho Clinical Diagnostics unit, which could fetch the US healthcare major around $5 billion
GSK sells thrombosis drugs to Aspen for $1.13 billion
01 Oct 2013
The sale comes a month after London-based GSK agreed to sell its Lucozade and Ribena soft drink brands to Japan's Suntory Beverages for £1.35 billion
Supreme Court bans all drug trials for lack of monitoring mechanism
30 Sep 2013
The Supreme Court today banned all clinical trials for new drugs until a suitable monitoring mechanism for human trials is put in place
